1. Home
  2. IMRN vs WETH Comparison

IMRN vs WETH Comparison

Compare IMRN & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • WETH
  • Stock Information
  • Founded
  • IMRN 1994
  • WETH 1992
  • Country
  • IMRN Australia
  • WETH China
  • Employees
  • IMRN N/A
  • WETH N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • IMRN Health Care
  • WETH
  • Exchange
  • IMRN Nasdaq
  • WETH Nasdaq
  • Market Cap
  • IMRN 9.2M
  • WETH 10.9M
  • IPO Year
  • IMRN N/A
  • WETH N/A
  • Fundamental
  • Price
  • IMRN $1.80
  • WETH $1.33
  • Analyst Decision
  • IMRN Strong Buy
  • WETH
  • Analyst Count
  • IMRN 1
  • WETH 0
  • Target Price
  • IMRN $5.00
  • WETH N/A
  • AVG Volume (30 Days)
  • IMRN 46.0K
  • WETH 266.7K
  • Earning Date
  • IMRN 08-29-2025
  • WETH 09-10-2025
  • Dividend Yield
  • IMRN N/A
  • WETH N/A
  • EPS Growth
  • IMRN N/A
  • WETH N/A
  • EPS
  • IMRN N/A
  • WETH 0.52
  • Revenue
  • IMRN $4,777,422.00
  • WETH $42,280,373.00
  • Revenue This Year
  • IMRN N/A
  • WETH N/A
  • Revenue Next Year
  • IMRN N/A
  • WETH N/A
  • P/E Ratio
  • IMRN N/A
  • WETH $2.56
  • Revenue Growth
  • IMRN 48.63
  • WETH 6.48
  • 52 Week Low
  • IMRN $1.50
  • WETH $0.76
  • 52 Week High
  • IMRN $2.87
  • WETH $2.96
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 48.13
  • WETH 67.54
  • Support Level
  • IMRN $1.80
  • WETH $1.15
  • Resistance Level
  • IMRN $1.94
  • WETH $1.42
  • Average True Range (ATR)
  • IMRN 0.08
  • WETH 0.13
  • MACD
  • IMRN -0.01
  • WETH 0.02
  • Stochastic Oscillator
  • IMRN 22.22
  • WETH 78.55

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: